Insider Trading - TAKEDA PHARMACEUTICAL CO LTD (TAK)
Real time insider trading transaction history:
- Insiders must file a Form 4 covering their trades within two business days.
- Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2018-03-19 Purchase | 2018-03-21 9:42 pm | Myovant Sciences Ltd. | MYOV | Takeda Pharmaceuticals International AG TAKEDA PHARMACEUTICAL CO LTD Takeda A/S Takeda Europe Holdings B.V. Takeda Pharma A/S 10% Owner | 7,420,625 | $18.67 | $138,543,069 | 7,420,625 (Indirect Direct) | View |
| 2018-03-19 Sale | 2018-03-21 9:42 pm | Myovant Sciences Ltd. | MYOV | Takeda Pharmaceuticals International AG TAKEDA PHARMACEUTICAL CO LTD Takeda A/S Takeda Europe Holdings B.V. Takeda Pharma A/S 10% Owner | 7,420,625 | $18.67 | $138,543,069 | 7,420,625 (Indirect Direct) | View |
| 2019-10-08 Purchase | 2019-11-22 06:23 am | Ovid Therapeutics Inc. | OVID | TAKEDA PHARMACEUTICAL CO LTD MILLENNIUM PHARMACEUTICALS INC 10% Owner | 2,000,000 | $2.5 | $5,000,000 | 5,750,000 (Indirect) | View |
| 2020-06-01 Sale | 2020-06-03 06:08 am | Translate Bio Inc. | TBIO | Shire Human Genetic Therapies Inc. TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 213,867 | $19.81 | $4,237,024 | 6,865,078 (Direct) | View |
| 2020-06-03 Sale | 2020-06-05 09:52 am | Translate Bio Inc. | TBIO | Shire Human Genetic Therapies Inc. TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 40,086 | $19.75 | $791,699 | 6,824,992 (Direct) | View |
| 2020-06-30 Sale | 2020-06-30 8:24 pm | Translate Bio Inc. | TBIO | Shire Human Genetic Therapies Inc. TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 6,824,992 | $20.68 | $141,140,835 | 0 (Direct) | View |
| 2021-05-03 Sale | 2021-05-05 08:26 am | Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 33,992 | $37 | $1,257,849 | 1,050,008 (Direct) | View |
| 2021-05-05 Sale | 2021-05-07 07:22 am | Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 7,138 | $35.14 | $250,803 | 1,042,870 (Direct) | View |
| 2021-05-07 Sale | 2021-05-11 06:30 am | Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 1,011 | $35.03 | $35,415 | 1,041,859 (Direct) | View |
| 2021-05-12 Sale | 2021-05-14 06:04 am | Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 11,876 | $35.44 | $420,892 | 1,029,983 (Direct) | View |
| 2021-05-14 Sale | 2021-05-18 06:02 am | Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 100 | $35 | $3,500 | 1,029,883 (Direct) | View |
| 2021-05-20 Sale | 2021-05-24 06:24 am | Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 18,746 | $35.5 | $665,439 | 1,011,137 (Direct) | View |
| 2021-05-24 Sale | 2021-05-26 09:42 am | Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 21,541 | $35.93 | $773,889 | 989,596 (Direct) | View |
| 2021-05-26 Sale | 2021-05-28 06:11 am | Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 20,811 | $36.84 | $766,700 | 968,785 (Direct) | View |
| 2021-05-28 Sale | 2021-06-02 06:08 am | Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 20,116 | $35.96 | $723,434 | 948,669 (Direct) | View |
| 2021-06-02 Sale | 2021-06-04 06:23 am | Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 4,300 | $35.18 | $151,274 | 944,369 (Direct) | View |
| 2021-06-07 Sale | 2021-06-09 06:41 am | Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 2,364 | $35.05 | $82,853 | 942,005 (Direct) | View |
| 2021-06-09 Sale | 2021-06-11 06:09 am | Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 3,293 | $35.19 | $115,883 | 938,712 (Direct) | View |
| 2021-06-14 Sale | 2021-06-16 06:06 am | Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 2,826 | $35.06 | $99,080 | 935,886 (Direct) | View |
| 2021-06-17 Sale | 2021-06-21 06:10 am | Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 8,703 | $35.11 | $305,571 | 927,183 (Direct) | View |
| 2021-06-21 Sale | 2021-06-23 06:15 am | Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 9,394 | $35.31 | $331,671 | 917,789 (Direct) | View |
| 2021-06-23 Sale | 2021-06-25 07:27 am | Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 11,048 | $35.14 | $388,199 | 906,741 (Direct) | View |
| 2021-06-25 Sale | 2021-06-29 06:44 am | Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 24,501 | $35.49 | $869,427 | 882,240 (Direct) | View |
| 2021-07-01 Sale | 2021-07-06 06:10 am | Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 8,326 | $35.16 | $292,727 | 873,914 (Direct) | View |
| 2021-07-07 Sale | 2021-07-09 06:09 am | Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 2,609 | $35.05 | $91,445 | 871,305 (Direct) | View |
| 2021-11-04 Sale | 2021-11-08 06:04 am | Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 1,000,001 | $20.85 | $20,850,019 | 7,459,304 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-05-13 Conversion | 2019-05-13 7:52 pm | N/A N/A | Cortexyme Inc. | CRTX | Takeda Ventures Inc. TAKEDA PHARMACEUTICAL CO LTD Takeda Pharmaceuticals International AG Takeda Pharmaceuticals U.S.A. Inc. 10% Owner | 5,359,604 | $0 | 2,679,802 (Direct) | View |
| 2021-10-12 Conversion | 2021-10-15 6:40 pm | N/A N/A | Theseus Pharmaceuticals Inc. | THRX | TAKEDA PHARMACEUTICAL CO LTD ARIAD PHARMACEUTICALS INC 10% Owner | 1,615,427 | $0 | 1,615,427 (Indirect) | View |
| 2021-10-26 Conversion | 2021-10-26 8:31 pm | N/A N/A | Xilio Therapeutics Inc. | XLO | TAKEDA PHARMACEUTICAL CO LTD Takeda Ventures Inc. 10% Owner | 2,950,242 | $0 | 1,475,121 (Indirect) | View |
| 2021-11-04 Exercise | 2021-11-08 06:04 am | 2019-10-29 2029-05-07 | Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 228,696 | $0 | 7,459,304 (Direct) | View |
| 2021-11-24 Other | 2021-11-29 5:16 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | TAKEDA PHARMACEUTICAL CO LTD Takeda Pharmaceuticals U.S.A. Inc. MILLENNIUM PHARMACEUTICALS INC Takeda Ventures Inc. 10% Owner | 57,224 | $0 | 6,584,830 (Indirect) | View |